FDMT Stock Analysis: Buy, Sell, or Hold?

FDMT - 4D Molecular Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$8.86
-0.11 (-1.23%) ▼
HOLD
MODERATE Confidence
Protect Your FDMT Gains
Last Updated: January 30, 2026
Earnings: Feb 27, 2026 26d

Get Alerted When FDMT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: FDMT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: FDMT is currently trading at $8.86, which is considered extended relative to its 30-day fair value range of $7.38 to $8.43.

Technical Outlook: Technically, FDMT is showing sideways momentum. Immediate support is located at $7.29, while resistance sits at $9.28.

Market Sentiment: FDMT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.11 (+269.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $7.38 - $8.43
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding FDMT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+5.1% above fair value)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 269.1% below Wall St target ($33.11)

Fair Price Analysis

30-Day Fair Range $7.38 - $8.43
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $7.30
Resistance Level $9.28
Current Trend Sideways

Fundamental Context

Forward P/E (Next Year Est.) -2.58
Wall Street Target $33.11 (+269.1%)
Revenue Growth (YoY) 2900.0%
Last updated: January 31, 2026 3:53 AM ET
Data refreshes hourly during market hours. Next update: 4:53 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott Bizily SELL 1635 shares 2025-10-16
Scott Bizily SELL 2408 shares 2025-10-09
Scott Bizily SELL 2407 shares 2025-09-23

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$66 46 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$112 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$90 59 HOLD
RNA
Avidity Biosciences Inc
STRONG BUY
15 analysts
$75 62 BUY
GPCR
Structure Therapeutics I…
STRONG BUY
14 analysts
$108 56 HOLD

Advanced FDMT Option Strategies

Professional options setups generated by AI based on today's FDMT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for FDMT

FDMT Technical Chart FDMT Price Prediction FDMT Earnings Date FDMT Investment Advisor FDMT Fair Price Analyzer FDMT Options Advisor FDMT Options Chain FDMT Options Analysis FDMT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals